Kids under twelve are currently ineligible for the vaccine, but trials are underway with high demand from families. As vaccination rates rise among teens, one twelve-year-old emphasizes the importance of getting vaccinated to return to normalcy. Breakthrough infections, while concerning, remain rare and typically lead to mild or asymptomatic cases, underscoring the overall effectiveness of vaccines.
